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Abstract   
 
Critical limb ischemia (CLI) is a terminal stage of peripheral artery disease (PAD); it is 
defined by the presence of resting pain and/or tissue loss for at least two weeks that may 
require urgent revascularization to promote healing and prevent limb loss. For patients with 
infrarenal aortoiliac occlusive disease, the revascularization options are surgery like 
aortofemoral bypass and axillofemoral bypass or percutaneous intervention. Aortoiliac and 
aortofemoral bypass procedures are associated with 74% to 95% 5-year patency rates, 
respectively, which are comparable but not superior to percutaneous therapies. These 
operations may imply a significant morbidity and mortality on CLI patients who usually have 
multiple comorbid conditions and are considered high risk patients. 
 
Keywords 
 
Critical limb ischemia, TASC-D lesion, Endovascular intervention, Peripheral artery disease, 
Aortoiliac 
 
Case description and method 
 
Our patient is a 52-year-old smoker female patient with past medical history of hypertension, 
hyperlipidemia and severe PAD with totally occluded infrarenal abdominal aorta just distal to 
the renal arteries, and known right axillofemoral bypass and fem-fem bypass. She presented 
with bilateral leg and foot pain at rest, diminished pulses and ulceration of the legs 
(Rutherford class VI). ABIs were obtained and were abnormal (right leg: ABI: 0.27, TBI:0. 
12. Left leg: ABI:0. 3, TBI: 0.12). CT angiography showed total occlusion of the axillo-fem-
fem bypass, totaled infra-renal aorta with reconstitution of peripheral circulation at the level 
of external iliac arteries bilaterally. These findings were confirmed by angiogram obtained by 
accessing right radial artery, as shown in figures 1, 2 and 3.  
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Figure 1: Angiogram of the right axillary artery showing occluded axillo-femoral bypass.  
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Figure 2: Aortogram showing occluded infrarenal aortic artery. 
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Figure 3: Angiogram right lower extremity showing reconstitution at the level right iliac artery 
bifurcation. Right external artery and common femoral artery are diffusely disease with multi focal 
stenosis. 
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Using the radial access in conjunction with ultrasound guided access to the right and left 
femoral arteries respectively, successful PTA and stents to the abdominal aorta using self 
expandable stent, also to the right and left common iliac arteries using covered stents in a 
kissing fashion as well as treatment of the right and left external iliac arteries were 
successfully obtained, as shown in figures 4, 5, 6, 7, 8 and 9. After three weeks follow up, the 
patient’s symptoms resolved, and she had good pulses bilaterally with healing ulcers and 
favorable ABIs (Right leg: ABI: 0.84, TBI: 0.68, Left leg: ABI: 0.82, TBI: 0.65). 
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Figure 4: Balloon angioplasty of the distal abdominal aorta and right common iliac artery. 
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Figure 5: Balloon angioplasty of the iliac arteries extending to the aorta. 
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Figure 6: Stenting of the abdominal aorta using a self-expandable stent.  
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Figure 7: Stenting of the right and left iliac artery in a kissing fashion. 
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 Figure 8: Angiogram image showing the abdominal aorta, right and left iliac stents after deployment.  
42
Amro, MD et al.: Endovascular Therapy of TASC-D Lesion in Critical Limb Ischemia, infrarenal aortoiliac occlusive disease
Published by Marshall University's Joan C. Edwards School of Medicine, 2016
  
Figure 9: Angiogram image of the left lower extremity showing restoration of flow in the distal aorta 
bilateral common iliac, left external iliac, left common femoral to the level of left superficial femoral 
artery. 
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Discussion 
 
CLI (Rutherford class IV-VI) is a terminal stage of peripheral artery disease (PAD); it is 
defined by the presence of resting pain and/or tissue loss for at least 2 weeks.1 The target of 
therapy of CLI is to restore pulsatile flow to the distal limb with as low procedural morbidity 
as possible.  
 
The Trans-Atlantic Inter-Society Consensus (TASC) document describes characteristic lesion 
morphology for ideal (type A) and unfavorable (type D) iliac lesions for endovascular 
therapy.4 The Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial was a 
British multicenter randomized trial that compared an initial strategy of angioplasty with 
open surgery in 452 patients with CLI. Overall, this trial showed that there was no significant 
difference in amputation-free survival (AFS) or overall survival (OS) between the two 
strategies. However, for those patients who survived for at least 2 years after randomization, 
a bypass surgery (BSX)-first revascularization strategy was associated with a significant 
increase in subsequent OS and a trend towards improved AFS compared to balloon 
angioplasty (BAP)-first revascularization strategies.5  
 
With advancement of technology and refinement of technical skills, endovascular therapy 
might be an option on a case-by-case basis. For patients with infrarenal aortoiliac occlusive 
disease, the revascularization options are surgery like aortofemoral bypass and axillofemoral 
bypass or percutaneous intervention. Aortoiliac and aortofemoral bypass procedures are 
associated with 74% to 95% 5-year patency rates, respectively, which are comparable but not 
superior to percutaneous therapies.2,3 Because many of these operations involve extensive 
abdominal incision, many of these operations may imply a significant morbidity and 
mortality on CLI patients who usually have multiple comorbid conditions and are considered 
high risk patients.  
 
Endovascular treatment of aortoiliac occlusive disease has high technical success rates of 82–
98%, even in the setting of aortic occlusion.6,7 Due to the availability and advancement of 
endovascular stents, the number of aortoiliac lesions that may be treated percutaneously has 
been increased significantly. For common iliac bifurcation lesions, kissing balloon–
expandable stents have become the preferred option. In small several series involving 
aortoiliac intervention, there was high success of stent placement, no major complications, 
symptomatic improvement, and 2-year patency rate approaching 87%.2  Endovascular 
treatment options include angioplasty and stenting; stenting has been shown to have higher 
patency and technical success than angioplasty, without increased complications.6,8  
 
In our case we used a self-expanding nitinol stent, which we recommend to use in these 
situations because they are widely used, require a smaller sheath size (6-7 Fr.), are simply 
deployed, and are less likely to interfere with the renal arteries flow after deployment. 
Ideally, assessment of the intraluminal diameter with IVUS is recommended, as the self-
expanding nitinol stents have limited sizes up to 14mm. In our case, we elected to proceed 
directly with 14 mm self expandable stent based on the fact that the size of the distal aorta in 
women above the age of 50 is 14.6 +/- 1.9 mm,9 which seemed to be reasonable to use.  
 
On the other hand a stent graft could be a valuable option for larger aortic diameter despite 
little evidence to support their use. There are several reports using stent grafts especially in 
active thrombosis. In atherosclerotic aortic disease, stent grafts do not increase the patency 
rates and theoretically increase the risk for ‘toothpasting’ possibly leading to embolization of 
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plaque and thrombus.6,10  Plaque embolization and migration might occur proximally and 
distally. Furthermore, in this case the chances of renal arteries occlusion might be higher 
given the nature of occlusion as illustrated in the angiogram. Endovascular treatment for 
infrarenal aortic disease can be performed with lower morbidity than with open surgery and 
with better durability than extra-anatomic bypass; however, there are no randomized 
controlled trial data to compare. 
 
Conclusion 
 
Endovascular treatment of infrarenal aortoiliac occlusive disease can be performed with 
lower morbidity than aortofemoral bypass and with better durability than axillofemoral 
bypass. Patients with TASC D lesions generally will be considered surgical candidates, but 
with the advancement of technology and availability of several endovascular stents, 
endovascular therapy might be an option on a case-by-case basis. 
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